RBRyan Billar

Ryan Billar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ryan Billar has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • J. Marco Schnater

    Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands, department of Pediatric Surgery

    2 shared publications
  • Joost van Rosmalen

    Erasmus Medical Center - Rotterdam, the Netherlands, department of biostatistics; Erasmus Medical Center - Rotterdam, the Netherlands, department of epidemiology

    2 shared publications
  • René Wijnen

    Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands, department of Pediatric Surgery

    2 shared publications
  • Serwet Demirdas

    Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands

    2 shared publications
  • A Y Rosalie Kühlmann

    Anaesthesiology, Saint Antonius Hospital, Nieuwegein, Utrecht, The Netherlands

    1 shared publication
  • Arnaud Vincent

    Erasmus Medical Center - Rotterdam, the Netherlands, department of neurosurgery

    1 shared publication

Latest Publications

  • Open Access

    The effect of recorded music on pain endurance (CRESCENDo) – A randomized controlled trial

    by Ryan Billar, Pablo Kappen, Sepehr Mohammadian, Corinne van Den Berg, Yolanda de Rijke, Erica van Den Akker, Joost van Rosmalen, J. Marco Schnater, Arnaud Vincent, Clemens Dirven, et al.


  • Open Access

    Early-Onset Pectus Excavatum Is More Likely to Be Part of a Genetic Variation

    by Ryan Billar, Stijn Heyman, Sarina Kant, René Wijnen, Frank Sleutels, Serwet Demirdas, J. Marco Schnater

    Background Potential underlying genetic variations of pectus excavatum (PE) are quite rare. Only one-fifth of PE cases are identified in the first decade of life and thus are of congenital origin. The objective of this study is to test if early-onset PE is more likely to be part of genetic variations than PE that becomes apparent during puberty or adolescence. Materials and Methods Children younger than 11 years who presented with PE to the outpatient clinic of the Department of Pediatric Surgery at our center between 2014 and 2020 were screened by two clinical geneticists separately. Molecular analysis was performed based on the differential diagnosis. Data of all young PE patients who already had been referred for genetic counseling were analyzed retrospectively. Results Pathogenic genetic variations were found in 8 of the 18 participants (44%): 3 syndromic disorders (Catel–Manzke syndrome and two Noonan syndromes), 3 chromosomal disorders (16p13.11 microduplication syndrome, 22q11.21 microduplication syndrome, and genetic gain at 1q44), 1 connective tissue disease (Loeys–Dietz syndrome), and 1 neuromuscular disorder (pathogenic variation in BICD2 gene). Conclusion Early-onset PE is more likely to be part of genetic variations than PE that becomes apparent during puberty or adolescence. Referral for genetic counseling should therefore be considered. Trial Registration: NCT05443113 Deidentified individual participant data will not be made available. R. B. conceived the study idea, coordinated the cohort study, wrote the first draft of the manuscript, interpreted the data, critically revised the manuscript, and made all figures and the final drafts of all tables. J. M. S. conceived the study idea, coordinated the cohort study, interpreted the data, and critically revised the manuscript. S. H., S. K., and S. D. coordinated the cohort study, interpreted the data, and critically revised the manuscript. F. S. interpreted the data and critically revised the manuscript. R. W. critically revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. * These authors contributed equally. Received: 04 April 2023 Accepted: 20 April 2023 Accepted Manuscript online: 26 April 2023 Article published online: 19 May 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Association between pectus excavatum and congenital genetic disorders: A systematic review and practical guide for the treating physician

    by Ryan J. Billar, Wiem Manoubi, Sarina G. Kant, René M.H. Wijnen, Serwet Demirdas, Johannes M. Schnater


  • Open Access

    Interventions with Music in PECTus excavatum treatment (IMPECT trial): a study protocol for a randomised controlled trial investigating the clinical effects of perioperative music interventions

    by Ryan J Billar, A Y Rosalie Kühlmann, J Marco Schnater, John Vlot, Jeremy J P Tomas, Gerda W Zijp, Mandana Rad, Sjoerd A de Beer, Markus F Stevens, Marten J Poley, et al.

    Introduction Pectus excavatum repair is associated with substantial postoperative pain, despite the use of epidural analgesia and other analgesic regimens. Perioperative recorded music interventions have been shown to alleviate pain and anxiety in adults, but evidence for children and adolescents is still lacking. This study protocol describes a randomised controlled trial that evaluates the effects of recorded music interventions on postoperative pain relief in children and adolescents after pectus excavatum repair. Methods A multicentre randomised controlled trial was set up comparing the effects of perioperative recorded music interventions in addition to standard care with those of standard care only in patients undergoing a Nuss procedure for pectus excavatum repair. One hundred and seventy subjects (12–18 years of age) will be included in three centres in the Netherlands. Patient inclusion has started in November 2018, and is ongoing. The primary outcome is self-reported perceived pain measured on the visual analogue scale. Secondary outcomes are anxiety level, analgesics consumption, vital parameters such as heart rate, blood pressure and respiratory rate, length of hospital stay, postoperative complications, quality of life and cost-effectiveness. Ethics and dissemination This study is being conducted in accordance with the Declaration of Helsinki. The Medical Ethics Review Board of Erasmus University Medical Centre Rotterdam, The Netherlands, has approved this protocol. Results will be disseminated via peer-reviewed scientific journals and conference presentations. Trial registration number NL6863